Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Duraiyah Thangathurai is a pioneering urologic surgeon and researcher whose work has fundamentally reshaped the surgical management of kidney cancer. His primary research focus lies in developing minimally invasive techniques that maximize oncologic control while minimizing patient morbidity. Dr. Thangathurai is best known for introducing the revolutionary concept of “zero ischemia” partial nephrectomy—a technique that eliminates the need to clamp the renal artery during tumor removal, thereby preserving kidney function. His landmark 2010 paper on this novel laparoscopic and robotic approach has garnered over 377 citations, establishing it as a cornerstone in nephron-sparing surgery. He further advanced the field by pioneering completely intracorporeal robotic level III and IV inferior vena cava tumor thrombectomy, one of the most challenging procedures in urologic oncology, with his initial series (142 citations) demonstrating its feasibility and safety. Dr. Thangathurai’s innovations, including anatomical renal artery branch microdissection, have been published in top journals and adopted globally. With over 900 total citations, his work continues to inspire a new generation of surgeons to push the boundaries of robotic-assisted surgery for complex renal malignancies.